Literature DB >> 9060822

Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.

D A Deubler1, B J Williams, X L Zhu, M R Steele, L R Rohr, J C Jensen, R A Stephenson, J E Changus, G J Miller, M J Becich, A R Brothman.   

Abstract

We have implemented a reliable new technique for preparing isolated prostate cancer nuclei from paraffin-embedded tissue sections followed by analysis with single-copy fluorescence in situ hybridization (FISH). Our initial validation is described by comparison of our data with fresh prostate tumor tissue and loss of heterozygosity (LOH) studies. We also describe evaluation of 36 previously unstudied prostate cancer patients. Fifteen archival samples were selected from patients who underwent radical prostatectomy in which direct FISH and LOH data were available. Isolated nuclei were prepared and allelic loss was detected on 17q using a single-copy DNA (P1 phage) probe by FISH. A high (80%) concordance was found when comparing isolated nuclei data with 17q results from fresh preparations and LOH studies. We also examined loss at sites on 8p, 10q, and 17q in samples from 36 patients for whom clinical information was available. Loss was found at any of the three loci in 32/36 (89%) of the specimens with specific loss in 53% of the cases at the 8p locus, 33% at the 10q locus, and 61% at the 17q locus. Studies indicate that, as well as providing potential clinical information, isolated nuclei preparations are as reliable as fresh tissue for single-copy FISH studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060822      PMCID: PMC1857886     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients.

Authors:  R Lundgren; S Heim; N Mandahl; H Anderson; F Mitelman
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

2.  Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

Authors:  U S Bergerheim; K Kunimi; V P Collins; P Ekman
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

3.  Allelotyping of human prostatic adenocarcinoma.

Authors:  K Kunimi; U S Bergerheim; I L Larsson; P Ekman; V P Collins
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

Review 4.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

5.  Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

Authors:  M L Cher; G S Bova; D H Moore; E J Small; P R Carroll; S S Pin; J I Epstein; W B Isaacs; R H Jensen
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

Review 6.  Epidemiologic evidence regarding predisposing factors to prostate cancer.

Authors:  B S Carter; H B Carter; J T Isaacs
Journal:  Prostate       Date:  1990       Impact factor: 4.104

7.  Chromosome study of five cancers of the prostate.

Authors:  N B Atkin; M C Baker
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Frequency and pattern of karyotypic abnormalities in human prostate cancer.

Authors:  A R Brothman; D M Peehl; A M Patel; J E McNeal
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

9.  Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate.

Authors:  R Lundgren; U Kristoffersson; S Heim; N Mandahl; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1988-10-01

10.  Allelic loss of chromosomes 16q and 10q in human prostate cancer.

Authors:  B S Carter; C M Ewing; W S Ward; B F Treiger; T W Aalders; J A Schalken; J I Epstein; W B Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

View more
  7 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.

Authors:  J Xu; S L Zheng; G A Hawkins; D A Faith; B Kelly; S D Isaacs; K E Wiley; B Chang ; C M Ewing; P Bujnovszky; J D Carpten; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

3.  Use of FISH analysis for prostate tumors and other tissue types.

Authors:  B Rautenstrauss; T Liehr; U M Schrell; H Grehl
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Chromosomal changes during development and progression of prostate adenocarcinomas.

Authors:  H Zitzelsberger; D Engert; A Walch; U Kulka; M Aubele; H Höfler; M Bauchinger; M Werner
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

5.  The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.

Authors:  A Vazina; J Baniel; Y Yaacobi; A Shtriker; D Engelstein; I Leibovitz; M Zehavi; A A Sidi; Y Ramon; T Tischler; P M Livne; E Friedman
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

6.  Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.

Authors:  K Ueda; M Nishijima; H Inui; M Watatani; E Yayoi; J Okamura; M Yasutomi; Y Nakamura; Y Miyoshi
Journal:  Jpn J Cancer Res       Date:  1998-01

7.  Chromosome 8 gain is associated with high-grade transformation in MPNST.

Authors:  Carina Dehner; Chang In Moon; Xiyuan Zhang; Zhaohe Zhou; Chris Miller; Hua Xu; Xiaodan Wan; Kuangying Yang; Jay Mashl; Sara Jc Gosline; Yuxi Wang; Xiaochun Zhang; Abigail Godec; Paul A Jones; Sonika Dahiya; Himanshi Bhatia; Tina Primeau; Shunqiang Li; Kai Pollard; Fausto J Rodriguez; Li Ding; Christine A Pratilas; Jack F Shern; Angela C Hirbe
Journal:  JCI Insight       Date:  2021-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.